NEAR VISION
Clinical trials for NEAR VISION explained in plain language.
Never miss a new study
Get alerted when new NEAR VISION trials appear
Sign up with your email to follow new studies for NEAR VISION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drops aim to replace reading glasses – but are they safe Long-Term?
Disease control CompletedThis phase 3 study tested the long-term safety of LNZ101 eye drops, a combination of aceclidine and brimonidine, in 362 adults aged 45-75 with presbyopia (age-related blurry near vision). Participants used the drops regularly and were monitored for side effects. The study is comp…
Matched conditions: NEAR VISION
Phase: PHASE3 • Sponsor: LENZ Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New eye drops could replace reading glasses for millions
Symptom relief CompletedThis study tested an eye drop called LNZ101 to help people with presbyopia (age-related trouble seeing up close) read without glasses. 469 adults aged 45-75 received the drops, and researchers measured how many gained clear near vision without losing distance vision on the first …
Matched conditions: NEAR VISION
Phase: PHASE3 • Sponsor: LENZ Therapeutics, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New eye drops could replace reading glasses for presbyopia
Symptom relief CompletedThis Phase 3 trial tested LNZ101 eye drops in 229 people aged 45-75 with presbyopia, a condition that makes it hard to see up close. The drops combine aceclidine and brimonidine to temporarily improve near vision. The main goal was to see if participants could read three lines be…
Matched conditions: NEAR VISION
Phase: PHASE3 • Sponsor: LENZ Therapeutics, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC